Eurofins PDMR share transactions
Analysis based on 32 articles · First reported May 22, 2026 · Last updated Jul 13, 2026
The PDMR transactions are routine and small in volume, unlikely to materially affect European Union — Eurofins' stock price. The disclosures reinforce transparency but have negligible market impact.
Eurofins Scientific SE disclosed multiple notifications of dealing by Persons Discharging Managerial Responsibilities (PDMRs) in June 2026. Analytical Bioventures S.C.A.., a company controlled by CEO Dr. Gilles Martin, acquired 5,000 shares on June 22-24 at prices between EUR 62.72 and EUR 66.58. Group CFO Laurent Lebras exercised 1,000 stock options and sold the resulting shares at EUR 65.00 on June 8. Senior Vice President François Vigneau exercised stock options and acquired shares on June 11 and 15 at EUR 32.50. These routine transactions comply with EU Market Abuse Regulation.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard